Inside ST-elevation myocardial infarction by monitoring concentrations of cardiovascular risk biomarkers in blood

Clinica Chimica Acta

Volumn 413, Issue 9-10, 2012, Pages 888-893

  Ferraro, Simona ^a,b   Ardoino, Ilaria ^b   Boracchi, Patrizia ^b   Santagostino, Matteo ^a   Ciardi, Laura ^a   Antonini, Giuseppina ^a   Braga, Federica ^b   Biganzoli, Elia ^b   Panteghini, Mauro ^b   Bongo, Angelo S ^a  

^a MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Biomarker; Interaction; Kinetic; Serum; ST elevation myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CHROMOGRANIN A; CLOPIDOGREL; CYSTATIN C; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TROPONIN I;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 84858618452     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.01.034     Document Type: Article

References (34)

1. Damman P., Beijk M.A., Kuijt W.J., et al. Multiple biomarkers at admission significantly improve the prediction of mortality in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. J Am Coll Cardiol 2011, 57:29-36.
2. Hassan A.K., Bergheanu S.C., Hasan-Ali H., et al. Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary intervention. Am J Cardiol 2009, 103:779-784.
3. Giannitsis E., Steen H., Kurz K., et al. Cardiac magnetic resonance imaging study for quantification of infarct size comparing directly serial versus single time-point measurements of cardiac troponin T. J Am Coll Cardiol 2008, 51:307-314.
4. Panteghini M., Cuccia C., Bonetti G., Giubbini R., Pagani F., Bonini E. Single-point cardiac troponin T at coronary care unit discharge after myocardial infarction correlates with infarct size and ejection fraction. Clin Chem 2002, 489:1432-1436.
5. Eggers K.M., Kempf T., Venge P., Wallentin L., Wollert K.C., Lindahl B. Improving long-term risk prediction in patients with acute chest pain: the Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected non necrosis biomarkers. Am Heart J 2010, 160:88-94.
6. Acikel S., Muderrisoglu H., Yildirir A., et al. Prevention of contrast-induced impairment of renal function by short-term or long-term statin therapy in patients undergoing elective coronary angiography. Blood Coagul Fibrinolysis 2010, 21:750-757.
7. Mega J.L., Morrow D.A., de Lemos J.A., et al. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction. An ENTIRE-TIMI-23 substudy. J Am Coll Cardiol 2004, 44:335-339.
8. Omland T., Dickstein K., Syversen U. Association between plasma chromogranin A concentration and long-term mortality after myocardial infarction. Am J Med 2003, 114:25-30.
9. Smith S.C., Feldman T.E., Hirshfeld J.W., et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (ACC/AHA/SCAI writing committee to update the 2001 guidelines for percutaneous coronary intervention). J Am Coll Cardiol 2006, 47:e1-e121.
10. Ricós C., Cava F., García-Lario J.V., et al. The reference change value: a proposal to interpret laboratory reports in serial testing based on biological variation. Scand J Clin Lab Invest 2004, 64:175-184.
11. Wu A.H., Lu Q.A., Todd J., Moecks J., Wians F. Short- and long-term biological variation in cardiac troponin I measured with a high-sensitivity assay: implications for clinical practice. Clin Chem 2009, 55:52-58.
12. Fokkema M.R., Herrmann Z., Muskiet F.A., Moecks J. Reference change values for brain natriuretic peptides revisited. Clin Chem 2006, 52:1602-1603.
13. D'Eril G.M., Anesi A., Maggiore M., Leoni V. Biological variation of serum amyloid A in healthy subjects. Clin Chem 2001, 47:1498-1499.
14. Dittadi R., Meo S., Gion M. Biological variation of plasma chromogranin A. Clin Chem Lab Med 2004, 42:109-110.
15. Bandaranayake N., Ankrah-Tetteh T., Wijeratne S., Swaminathan R. Intra-individual variation in creatinine and cystatin C. Clin Chem Lab Med 2007, 45:1237-1239.
16. Hedeker D., Gibbons R.D. Longitudinal data analysis 2006, John Wiley & Sons.
17. Ferraro S., Lupi A., Marano G., et al. Different patterns of NT-proBNP secretion in acute coronary syndromes. Clin Chim Acta 2009, 402:176-181.
18. Littell R.C., Milliken G.A., Stroup W.W. SAS® for mixed models 2006, SAS Press. 2nd ed.
19. Alpert J.S., Thygesen K., Antman E., Bassand J.P. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000, 36:959-969.
20. Di Stefano R., Di Bello V., Barsotti M.C., et al. Inflammatory markers and cardiac function in acute coronary syndrome: difference in ST-segment elevation myocardial infarction (STEMI) and in non-STEMI models. Biomed Pharmacother 2009, 63:773-780.
21. Kurz K., Schild C., Isfort P., Katus H.A., Giannitsis E. Serial and single time-point measurements of cardiac troponin T for prediction of clinical outcomes in patients with acute ST-segment elevation myocardial infarction. Clin Res Cardiol 2009, 98:94-100.
22. Licka M., Zimmermann R., Zehelein J., Dengler T.J., Katus H.A., Kübler W. Troponin T concentrations 72 hours after myocardial infarction as a serological estimate of infarct size. Heart 2002, 87:520-524.
23. Jaffe A.S., Apple F.S., Morrow D.A., Lindahl B., Katus H.A. Being rational about (im)precision: a statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology/ American College of Cardiology Foundation/American Heart Association/World Heart Federation Task Force for the definition of myocardial infarction. Clin Chem 2010, 56:941-943.
24. Clerico A., Zucchelli G., Pilo A., Passino C., Emdin M. Clinical relevance of biological variation: the lesson of brain natriuretic peptide. Clin Chem Lab Med 2006, 44:366-378.
25. Fraser C.G., Fogarty Y. Interpreting laboratory results. Br Med J 1989, 298:1659-1660.
26. Vakili B.A., Kaplan R.C., Brown D.L. Sex-based differences in early mortality of patients undergoing primary angioplasty for first acute myocardial infarction. Circulation 2001, 104:3034-3038.
27. Berger J.S., Brown D.L. Gender-age interaction in early mortality following primary angioplasty for acute myocardial infarction. Am J Cardiol 2006, 98:1140-1143.
28. Ferrero E., Scabini S., Magni E., et al. Chromogranin A protects vessels against tumor necrosis factor alpha-induced vascular leakage. FASEB J 2004, 18:554-556.
29. Lambert G., Grassi G. Indices of sympathetic activity and the paradox of chromogranin A. J Hypertens 2010, 28:676-678.
30. Tanaka A., Shimada K., Sano T., et al. Multiple plaque rupture and C-reactive protein in acute myocardial infarction. J Am Coll Cardiol 2005, 45:1594-1599.
31. Kuch B., von Scheidt W., Kling B., Heier M., Hoermann A., Meisinger C. Differential impact of admission C-reactive protein levels on 28-day mortality risk in patients with ST-elevation versus non-ST-elevation myocardial infarction. Am J Cardiol 2008, 102:1125-1130.
32. Saleh N., Svane B., Hansson L.O., et al. Response of serum C-reactive protein to percutaneous coronary intervention has prognostic value. Clin Chem 2005, 51:2124-2130.
33. Ichimoto E., Jo K., Kobayashi Y., et al. Prognostic significance of cystatin C in patients with ST-elevation myocardial infarction. Circ J 2009, 73:1669-1673.
34. Stefanini F.M., Coradini D., Biganzoli E. Conditional independence relations among biological markers may improve clinical decision as in the case of triple negative breast cancers. BMC Bioinformatics 2009, 10(Suppl 12):S13.